Medica Group Plc provides teleradiology reporting services to NHS trusts, private hospital groups, and diagnostic imaging companies in the United Kingdom. More Details
High growth potential with excellent balance sheet.
Share Price & News
How has Medica Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: MGP is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: MGP's weekly volatility (5%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: MGP underperformed the UK Healthcare industry which returned 59.2% over the past year.
Return vs Market: MGP exceeded the UK Market which returned 27.6% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Medica Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
4 days ago | Simply Wall StMedica Group Plc Just Missed Earnings - But Analysts Have Updated Their Models
1 week ago | Simply Wall StWhat Type Of Shareholders Make Up Medica Group Plc's (LON:MGP) Share Registry?
1 month ago | Simply Wall StAre Insiders Selling Medica Group Plc (LON:MGP) Stock?
Is Medica Group undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: MGP (£1.59) is trading below our estimate of fair value (£1.94)
Significantly Below Fair Value: MGP is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: MGP is poor value based on its PE Ratio (131.4x) compared to the UK Healthcare industry average (40.9x).
PE vs Market: MGP is poor value based on its PE Ratio (131.4x) compared to the UK market (25.7x).
Price to Earnings Growth Ratio
PEG Ratio: MGP is poor value based on its PEG Ratio (4.9x)
Price to Book Ratio
PB vs Industry: MGP is overvalued based on its PB Ratio (4.8x) compared to the GB Healthcare industry average (2.1x).
How is Medica Group forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MGP's forecast earnings growth (27% per year) is above the savings rate (0.9%).
Earnings vs Market: MGP's earnings (27% per year) are forecast to grow faster than the UK market (17.6% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: MGP's revenue (16% per year) is forecast to grow faster than the UK market (5.3% per year).
High Growth Revenue: MGP's revenue (16% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MGP's Return on Equity is forecast to be high in 3 years time (22.7%)
How has Medica Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MGP has high quality earnings.
Growing Profit Margin: MGP's current net profit margins (3.7%) are lower than last year (17%).
Past Earnings Growth Analysis
Earnings Trend: MGP's earnings have grown by 13.3% per year over the past 5 years.
Accelerating Growth: MGP's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: MGP had negative earnings growth (-83%) over the past year, making it difficult to compare to the Healthcare industry average (1.3%).
Return on Equity
High ROE: MGP's Return on Equity (3.7%) is considered low.
How is Medica Group's financial position?
Financial Position Analysis
Short Term Liabilities: MGP's short term assets (£22.3M) exceed its short term liabilities (£14.1M).
Long Term Liabilities: MGP's short term assets (£22.3M) exceed its long term liabilities (£16.6M).
Debt to Equity History and Analysis
Debt Level: MGP's debt to equity ratio (48.9%) is considered high.
Reducing Debt: MGP's debt to equity ratio has reduced from 913.2% to 48.9% over the past 5 years.
Debt Coverage: MGP's debt is well covered by operating cash flow (48.4%).
Interest Coverage: MGP's interest payments on its debt are well covered by EBIT (7.3x coverage).
What is Medica Group current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: MGP's dividend (1.6%) is higher than the bottom 25% of dividend payers in the UK market (1.37%).
High Dividend: MGP's dividend (1.6%) is low compared to the top 25% of dividend payers in the UK market (4.09%).
Stability and Growth of Payments
Stable Dividend: MGP has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: MGP's dividend payments have increased, but the company has only paid a dividend for 4 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (70.2%), MGP's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: MGP's dividends in 3 years are forecast to be well covered by earnings (30.5% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Dr. Stuart Quin, Ph.D., serves as Chief Executive Officer and Director of Medica Group Plc since September 1, 2019. Dr. Quin joins Medica from Synlab, where he was Head of Central and Eastern Europe, Middl...
CEO Compensation Analysis
Compensation vs Market: Stuart's total compensation ($USD537.11K) is about average for companies of similar size in the UK market ($USD568.00K).
Compensation vs Earnings: Insufficient data to compare Stuart's compensation with company performance.
Experienced Management: MGP's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Experienced Board: MGP's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.2%.
Medica Group Plc's company bio, employee growth, exchange listings and data sources
- Name: Medica Group Plc
- Ticker: MGP
- Exchange: LSE
- Founded: 2013
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: UK£194.601m
- Shares outstanding: 122.39m
- Website: https://www.medicagroup.co.uk
Number of Employees
- Medica Group Plc
- One Priory Square
- 6th Floor
- East Sussex
- TN34 1EA
- United Kingdom
Medica Group Plc provides teleradiology reporting services to NHS trusts, private hospital groups, and diagnostic imaging companies in the United Kingdom. It offers NightHawk emergency computerised tomogra...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/05/17 02:48|
|End of Day Share Price||2021/05/14 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.